Bisoprolol Fumarate is the most selective beta-1 blocker. It has highest level of affinity for the beta-1 receptor than any other beta-blocker available up to now. It selectively blocks beta-1 adrenergic receptor in the heart and vascular smooth muscle and reduces heart rate and cardiac output resulting in decrease of arterial hypertension. Lipid metabolism can be adversely affected by beta-1 blockers, in patients with non-selective beta-blocker, but Bisoprolol does not cause any change in the cholesterol fraction including the cardioprotective HDL-cholesterol in long-term therapy.
Ancor-2.5 Tablet: Each tablet contains Bisoprolol Fumarate USP 2.5 mg.
Ancor-5 Tablet: Each tablet contains Bisoprolol Fumarate USP 5 mg.
Ancor-10 Tablet: Each tablet contains Bisoprolol Fumarate USP 10 mg.
Hypertension, angina and adjunct in stable moderate to severe heart failure
Hypertension and angina: Usually 5-10 mg once daily, max. 20 mg daily, Moderate to severe heart failure: Initially 1.25 mg once daily (in the morning) for 1 week then, if well tolerated, increased to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then 7.5 mg once daily for 4 weeks, then 10 mg once daily; max.10 mg daily.
In patients with cardiogenic shock, overt heart failure, second or third degree A-V block, right ventricular failure secondary to pulmonary hypertension and sinus bradycardia.
Monitoring of renal, hepatic, and hematopoietic function should be performed at regular intervals during long-term treatment with bisoprolol.
Gastro-intestinal disturbances, bradycardia, hypotension, peripheral vasoconstriction, headache, fatigue, sleep disturbances, dizziness, vertigo, sexual dysfunction; thrombocytopenia; visual disturbances, alopecia may be occurred.
Bisoprolol should not be combined with other beta-blocking agents.
Use in pregnancy: The safety of bisoprolol during pregnancy has not been established
Use in lactation: No data is available for lactation.
Use in children: Safety and effectiveness in children have not been established.
Ancor-2.5 Tablet: Each box contains 30â€™s tablets in blister pack.
Ancor-5 Tablet: Each box contains 30â€™s tablets in blister pack.
Ancor-10 Tablet: Each box contains 10â€™s tablets in blister pack
Aristopharma Ltd. is one of the top 10 pharmaceutical companies in Bangladesh. The company started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen.
© 2022. Aristopharma Ltd. All rights reserved.